Compare Organon Pharma Indonesia Tbk. (SCPI) vs Wahana Pronatural Tbk. (WAPO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Wahana Pronatural Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Wahana Pronatural Tbk. trades at Rp185 (market cap 229.57B, 6.8M 24h volume). The key difference: Wahana Pronatural Tbk. is far larger — about 2.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | WAPO | |
|---|---|---|
Market Cap | 104.4B | 229.57B |
Volume | — | 6.8M |
Lot | — | 68.05K |
Turnover | — | 1.26B |
Average Price | — | 184.51 |
Value | — | 1.26B |
Indicative Equilibrium Price | — | 185 |
Indicative Equilibrium Volume | — | 2.93K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Wahana Pronatural Tbk.
PT Wahana Phonix Mandiri (the Company) Tbk was established on August 7, 1993 under the name PT Golden Phoenix. On January 31, 2000 the Company changed its named to be PT Wahana Phonix Mandiri, Tbk. Deed by making statements shareholders meeting extraordinary No.2 on June 2, 2012 by Wachid Hasyim, notary in Surabaya, the Company name was changed to PT Wahana Pronatural Tbk
Read more on WAPO →
